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Cannabinoid (CB) receptors have gained much attention
as markers for various brain tumours and potential thera-
peutic targets of neuropathic pain and mood disorders.
Two CB receptors have been cloned and described: CB1,
predominantly expressed in the brain and CB2, primarily
found in the peripheral system but also in brain. The CB2
receptor is suggested to be involved in various neurode-
generative diseases, such as Alzheimer’s or Parkinson’s dis-
ease [1]. Early and non-invasive diagnosis and therapy
monitoring of such diseases is desired. Positron-Emission-
Tomography (PET) allows imaging of functional processes
in living humans. For this, compounds with positron emit-
ting labels like 18F are used. Due to the high sensitivity of
PET, such radiotracers must bind to the target protein
with high selectivity.
Here, we utilise AutoGPA [2] implemented in the mod-
elling suite MOE (Chemical Computing Group Inc., Mon-
treal) to compute grid potentials build upon a 3D-QSAR
model derived from a library of CB2 selective N-Aryl-oxa-
diazolyl-propionamides. Since a proper alignment of the
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molecules prior the analysis is crucial to the successful
application of these models in further studies, the mole-
cules were aligned based on their pharmacophore features.
The obtained model delivers also knowledge of the
3D-structure of the binding site, which, in turn, can be
used to refine 3D-models of the CB2 receptor. The steric
and electrostatic contour maps are applied for identifica-
tion of regions suitable for labelling with 18F, the most
preferred PET radionuclide.
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